Detalhe da pesquisa
1.
A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D.
N Engl J Med
; 389(1): 22-32, 2023 Jul 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37345876
2.
Blocking viral entry with bulevirtide reduces the number of HDV-infected hepatocytes in human liver biopsies.
J Hepatol
; 80(6): 882-891, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38340811
3.
Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase 3 randomized trial.
J Hepatol
; 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38734383
4.
Real-world safety and effectiveness of tenofovir alafenamide for 144 weeks in Japanese patients with chronic hepatitis B.
J Viral Hepat
; 31(4): 165-175, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38163911
5.
No virologic resistance to bulevirtide monotherapy detected in patients through 24 weeks treatment in phase II and III clinical trials for chronic hepatitis delta.
J Hepatol
; 79(3): 657-665, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37120031
6.
Long-term Treatment With Tenofovir Alafenamide for Chronic Hepatitis B Results in High Rates of Viral Suppression and Favorable Renal and Bone Safety.
Am J Gastroenterol
; 2023 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37561058
7.
Nutritional needs, resources, and barriers among unhoused adults cared for by a street medicine organization in Chicago, Illinois: a cross-sectional study.
BMC Public Health
; 23(1): 2430, 2023 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38057780
8.
Characterization of Hepatitis B virus polymerase mutations A194T and CYEI and tenofovir disoproxil fumarate or tenofovir alafenamide resistance.
J Viral Hepat
; 28(1): 30-39, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32894807
9.
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis.
J Hepatol
; 73(6): 1368-1378, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32707225
10.
Longitudinal analysis of serum microRNAs as predictors of cirrhosis regression during treatment of hepatitis B virus infection.
Liver Int
; 40(7): 1693-1700, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32301252
11.
Cutaneous manifestations of Campylobacter jejuni infection: A case report and review of the literature.
Infect Dis Clin Pract (Baltim Md)
; 28(2): 61-63, 2020 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34012223
12.
Ten-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B virus infection.
Liver Int
; 39(10): 1868-1875, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31136052
13.
96â¯weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection.
J Hepatol
; 68(4): 672-681, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29756595
14.
No Resistance to Tenofovir Alafenamide Detected through 96 Weeks of Treatment in Patients with Chronic Hepatitis B Infection.
Antimicrob Agents Chemother
; 62(10)2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30038044
15.
Improved Bone Safety of Tenofovir Alafenamide Compared to Tenofovir Disoproxil Fumarate Over 2 Years in Patients With Chronic HBV Infection.
Clin Gastroenterol Hepatol
; 2018 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29933096
16.
Tenofovir disoproxil fumarate (TDF) vs. emtricitabine (FTC)/TDF in lamivudine resistant hepatitis B: A 5-year randomised study.
J Hepatol
; 66(1): 11-18, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27545497
17.
Factors Associated With Persistent Increase in Level of Alanine Aminotransferase in Patients With Chronic Hepatitis B Receiving Oral Antiviral Therapy.
Clin Gastroenterol Hepatol
; 15(7): 1087-1094.e2, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28215615
18.
Impact of a discharge prescription program on hospital readmissions and patient satisfaction.
J Am Pharm Assoc (2003)
; 57(4): 498-502.e1, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28551305
19.
Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B.
Cancer
; 121(20): 3631-8, 2015 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26177866
20.
A pharmacogenetic candidate gene study of tenofovir-associated Fanconi syndrome.
Pharmacogenet Genomics
; 25(2): 82-92, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25485598